Sulfacytine
Appearance
(Redirected from Renoquid)
This article needs additional citations for verification. (September 2015) |
![]() | |
Clinical data | |
---|---|
Other names | 1-ethyl N4-sulfanilylcytosin, 1-ethyl-N-sulfanilylcytosine, N-sulfanilyl-l-ethylcytosine, Sulfacitina [inn-spanish], Sulfacitinum [inn-latin] |
Routes of administration | Oral |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
PubChem SID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C12H14N4O3S |
Molar mass | 294.33 g·mol−1 |
3D model (JSmol) | |
| |
|
Sulfacytine is a short-acting sulfonamide antibiotic, taken orally for treatment against bacterial infections. Sulfonamides, as a group of antibiotics, work by inhibiting the bacterial synthesis of folate.[1] In 2006 the drug was discontinued[2][3]
References
[edit]- ^ DrugBank DB01298
- ^ Federal Register Section: Food and Drug Administration [Docket No. 2006N–0222] Merck & Co., Inc., et al.; Withdrawal of Approval of 65 New Drug Applications and 52 Abbreviated New Drug Applications] Vol. 71, No. 116 / Friday, June 16, 2006. p34941
- ^ FDA Orange book. Sulfacytine Page accessed May 12, 2015